Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification.

J Thorac Oncol 2016 07 14;11(7):e83-5. Epub 2016 Mar 14.

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.02.021DOI Listing
July 2016
12 Reads

Publication Analysis

Top Keywords

crizotinib patient
4
lung cancer
4
harboring novo
4
patient advanced
4
advanced egfr-mutant
4
egfr-mutant lung
4
erlotinib crizotinib
4
novo met
4
met amplification
4
response combination
4
cancer harboring
4
combination erlotinib
4
dramatic response
4
harboring
1
met
1
amplification
1
novo
1
egfr-mutant
1
crizotinib
1
erlotinib
1

Altmetric Statistics

Similar Publications